CoChat
Sign Up
Cited by 13Alzheimer's disease research and treatmentsProtein Kinase Regulation and GTPase SignalingAutophagy in Disease and Therapy

Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents

Open access
Maestro, Ines, Madruga, Enrique, Boya, Patricia, Martínez, Ana·2023·Journal of Enzyme Inhibition and Medicinal Chemistry
DOI 10.1080/14756366.2022.2153841PMC PMC9848319
Open this paper in CoChat — free account

Abstract

model of AD and ii) block mitophagy in a PRKN-independent manner, reinforcing the hypothesis of SGK1 inhibitors as neuroprotective chemical tools.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/14756366.2022.2153841

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. [1]Lang F, Artunc F, Vallon V. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1. Curr Opin Nephrol Hypertens. 2009; 18(5): 439– 448. 19584721 PMC2883450
  2. [2]Lang F, Stournaras C, Zacharopoulou N, Voelkl J, Alesutan I. Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress. Cell Stress. 2018; 3(1): 1– 8. 31225494 PMC6551677
  3. [3]Engelsberg A, Kobelt F, Kuhl D. The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover. Biochem J. 2006; 399(1): 69– 76. 16776652 PMC1570167
  4. [4]Zhao B, Lehr R, Smallwood AM, Ho TF, Maley K, Randall T, Head MS, Koretke KK, Schnackenberg CG. Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP. Protein Sci. 2007; 16(12): 2761– 2769. 17965184 PMC2222817
  5. [5]Hammond M, Washburn DG, Hoang HT, Manns S, Frazee JS, Nakamura H, Patterson JR, Trizna W, Wu C, Azzarano LM, et al. Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1(SGK1) inhibitors. Bioorg Med Chem Lett. 2009; 19(15): 4441– 4445. 19497745
  6. [6]Cheng HC, Qi RZ, Paudel H, Zhu HJ. Regulation and function of protein kinases and phosphatases. Enzyme Res. 2011; 2011: 794089. 22195276 PMC3238372
  7. [7]Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 2009; 9(1): 28– 39. 19104514 PMC12406740
  8. [8]Roskoski R. Jr., Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update. Pharmacol Res. 2022; 175: 106037. 34921994
  9. [9]Maestro I, Boya P, Martinez A. Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases. Expert Opin Ther Targets. 2020; 24(3): 231– 243. 32067528
  10. [10]Schoenebeck B, Bader V, Zhu XR, Schmitz B, Lubbert H, Stichel CC. Sgk1, a cell survival response in neurodegenerative diseases. Mol Cell Neurosci. 2005; 30(2): 249– 264. 16125969
  11. [11]Iwata S, Nomoto M, Morioka H, Miyata A. Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice. Synapse. 2004; 51(4): 279– 286. 14696015
  12. [13]Virdee K, Yoshida H, Peak-Chew S, Goedert M. Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. FEBS Lett. 2007; 581(14): 2657– 2662. 17512525
  13. [14]Duka V, Lee JH, Credle J, Wills J, Oaks A, Smolinsky C, Shah K, Mash DC, Masliah E, Sidhu A. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer’s diseases. PLoS One. 2013; 8(9): e75025. 24073234 PMC3779212
  14. [17]Ortuso F, Amato R, Artese A, D'Antona L, Costa G, Talarico C, Gigliotti F, Bianco C, Trapasso F, Schenone S, et al. In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold. J Chem Inf Model. 2014; 54(7): 1828– 1832. 24896223
  15. [18]Mehrpour M, Esclatine A, Beau I, Codogno P. Overview of macroautophagy regulation in mammalian cells. Cell Res. 2010; 20(7): 748– 762. 20548331
  16. [19]Ballesteros-Alvarez J, Andersen JK. mTORC2: The other mTOR in autophagy regulation. Aging Cell. 2021; 20(8): e13431. 34250734 PMC8373318
  17. [20]Lu M, Wang J, Jones KT, Ives HE, Feldman ME, Yao LJ, Shokat KM, Ashrafi K, Pearce D. mTOR complex-2 activates ENaC by phosphorylating SGK1. J Am Soc Nephrol. 2010; 21(5): 811– 818. 20338997 PMC2865740
  18. [21]Zuleger T, Heinzelbecker J, Takacs Z, Hunter C, Voelkl J, Lang F, Proikas-Cezanne T. SGK1 Inhibits Autophagy in Murine Muscle Tissue. Oxid Med Cell Longev. 2018; 2018: 4043726. 29849891 PMC5937381
  19. [22]Liu W, Wang X, Liu Z, Wang Y, Yin B, Yu P, Duan X, Liao Z, Chen Y, Liu C, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway. Br J Cancer. 2017; 117(8): 1139– 1153. 29017179 PMC5674106
  20. [23]Liu W, Wang X, Wang Y, Dai Y, Xie Y, Ping Y, Yin B, Yu P, Liu Z, Duan X, et al. SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT. J Exp Clin Cancer Res. 2018; 37(1): 73. 29609629 PMC5879613
  21. [24]Tang X, Sun Y, Xu C, Guo X, Sun J, Pan C, Sun J. Caffeine Induces Autophagy and Apoptosis in Auditory Hair Cells via the SGK1/HIF-1alpha Pathway. Front Cell Dev Biol. 2021; 9: 751012. 34869338 PMC8637128
  22. [25]Maestro I, de la Ballina LR, Simonsen A, Boya P, Martinez A. Phenotypic Assay Leads to Discovery of Mitophagy Inducers with Therapeutic Potential for PRKNson’s Disease. ACS Chem Neurosci. 2021; 12(24): 4512– 4523. 34846852
  23. [26]Wang Y, Liu N, Lu B. Mechanisms and roles of mitophagy in neurodegenerative diseases. CNS Neurosci Ther. 2019; 25(7): 859– 875. 31050206 PMC6566062
  24. [27]Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 7: 42717. 28256516 PMC5335600
  25. [28]Daina A, Zoete V. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem. 2016; 11(11): 1117– 1121. 27218427 PMC5089604
  26. [32]Sebastian-Perez V, Roca C, Awale M, Reymond JL, Martinez A, Gil C, Campillo NE. Medicinal and Biological Chemistry(MBC) Library: An Efficient Source of New Hits. J Chem Inf Model. 2017; 57(9): 2143– 2151. 28813151
  27. [33]Princely Abudu Y, Pankiv S, Mathai BJ, Hakon Lystad A, Bindesboll C, Brenne HB, Yoke Wui Ng M, Thiede B, Yamamoto A, Mutugi Nthiga T, et al. NIPSNAP1 and NIPSNAP2 Act as “Eat Me” Signals for Mitophagy. Dev Cell. 2019; 49(4): 509– 525 e12. 30982665 PMC12335005
  28. [34]Allen GF, Toth R, James J, Ganley IG. Loss of iron triggers PINK1/PRKN-independent mitophagy. EMBO Rep. 2013; 14(12): 1127– 1135. 24176932 PMC3981094
  29. [35]Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006; 7(10): R100. 17076895 PMC1794559
  30. [36]Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem. 2003; 38(3): 223– 232. 12667689
  31. [37]Pantsar T, Poso A. Binding Affinity via Docking: Fact and Fiction. Molecules. 2018; 23(8): 1899. 30061498 PMC6222344
  32. [38]Tang MY, Vranas M, Krahn AI, Pundlik S, Trempe JF, Fon EA. Structure-guided mutagenesis reveals a hierarchical mechanism of PRKN activation. Nat Commun. 2017; 8: 14697. 28276439 PMC5347139
  33. [39]Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991; 266(26): 17707– 17712. 1832676
  34. [40]Kamat PK, Rai S, Nath C. Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer’s disease pathology. Neurotoxicology. 2013; 37: 163– 172. 23688530

Cited by

Sorted by citations

Authors
Maestro, I., Madruga, E., Boya, P., & Martínez, A.
Affiliations
  • Centro de Investigaciones, Biológicas Margarita Salas-CSIC
  • Consejo Superior de Investigaciones Científicas (ES)
ORCID
Venue
Journal of Enzyme Inhibition and Medicinal Chemistry
Publisher
Informa UK Limited
Published
2023-01-13
Volume
38
Issue
1
Pages
2153841-2153841
ISSN
  • 1475-6366 (ISSN-L)
  • 1475-6374
DOI
10.1080/14756366.2022.2153841
PMC
PMC9848319
OpenAlex
W4315928283
Cited by
13
References
3
Citations by year
2026: 2 · 2025: 5 · 2024: 5 · 2023: 1
FWCI
2.31
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Enzyme Inhibition and Medicinal Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CB18/05/00040)
  • Horizon 2020 Framework Programme (H2020-MSCA, 765912, PID2019, H2020-MSCA-ITN-2017, H2020-MSCA-ITN)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
SGK1 inhibitor, structural families, neuroprotection, Alzheimer's disease, mitophagy, kinase inhibitors
MeSH terms
Apoptosis, Protein Serine-Threonine Kinases, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review